Pediatric Pulmonary Vascular Disease Specialist
Pediatric Cardiology
Dr. Ian T. Adatia, MD
|
|
Give Review
Doctor Ian T. Adatia, MD is an expert in the field of Pediatric Cardiology. He attended University of Bristol Medical School. Adatia is a published doctor. He has 90 publications published. The most current publication "From functional pulmonary atresia to right ventricular restriction. Long term follow up of Uhl''s anomaly."
Publications
- Recommendations for the Use of Inhaled Nitric Oxide Therapy in Premature Newborns with Severe Pulmonary Hypertension.
- Change in Pediatric Functional Classification During Treatment and Morbidity and Mortality in Children with Pulmonary Hypertension.
- Preoperative B-type natriuretic peptide levels are associated with outcome after total cavopulmonary connection (Fontan).
- B-type natriuretic peptide levels predict outcomes in infants undergoing cardiac surgery in a lesion-dependent fashion.
- Implications of the U.S. Food and Drug Administration Warning against the Use of Sildenafil for the Treatment of Pediatric Pulmonary Hypertension.
- Endostatin, an inhibitor of angiogenesis, decreases after bidirectional superior cavopulmonary anastamosis.
- Pulmonary Interstitial Glycogenosis: An Unrecognized Etiology of Persistent Pulmonary Hypertension of the Newborn in Congenital Heart Disease?
- Early postoperative care of patients with pulmonary hypertension associated with congenital cardiac disease.
- Immediate postoperative care.
- Sudden unexpected death in children with heart disease.
- Perioperative B-type natriuretic peptide levels predict outcome after bidirectional cavopulmonary anastomosis and total cavopulmonary connection.
- B-type natriuretic peptide levels predict outcomes for children on extracorporeal life support after cardiac surgery.
- B-type natriuretic peptide levels predict outcome after neonatal cardiac surgery.
- Congenital diaphragmatic hernia and associated cardiovascular malformations: type, frequency, and impact on management.
- CT of the chest in the evaluation of idiopathic pulmonary arterial hypertension in children.
- Regional and central venous oxygen saturation monitoring following pediatric cardiac surgery: concordance and association with clinical variables.
- Summary proceedings from the cardiology group on postoperative cardiac dysfunction.
- Nebulized therapies for childhood pulmonary hypertension: an in vitro model.
- Extracorporeal life support after staged palliation of a functional single ventricle: subsequent morbidity and survival.
- Contemporary management of right atrial isomerism: effect of evolving therapeutic strategies.
- The price of success in the management of congenital diaphragmatic hernia: is improved survival accompanied by an increase in long-term morbidity?
- Resting and exercise cardiorespiratory function in survivors of congenital diaphragmatic hernia.
- Alterations in plasma B-type natriuretic peptide levels after repair of congenital heart defects: a potential perioperative marker.
- Alveolar capillary dysplasia: a six-year single center experience.
- Relation of limiting ductal patency to survival in neonatal Ebstein's anomaly.
- Improving the outcome of childhood pulmonary arterial hypertension: the effect of bosentan in the setting of a dedicated pulmonary hypertension clinic.
- Beneficial effect of oral sildenafil therapy on childhood pulmonary arterial hypertension: twelve-month clinical trial of a single-drug, open-label, pilot study.
- Effect of carbon dioxide on systemic oxygenation, oxygen consumption, and blood lactate levels after bidirectional superior cavopulmonary anastomosis.
- Inhaled nitric oxide does not improve systemic oxygenation after bidirectional superior cavopulmonary anastomosis.
- Rapid advancement to more concentrated formula in infants after surgery for congenital heart disease reduces duration of hospital stay: a randomized clinical trial.
- The effects of carbon dioxide on oxygenation and systemic, cerebral, and pulmonary vascular hemodynamics after the bidirectional superior cavopulmonary anastomosis.
- Early determinants of pulmonary vascular remodeling in animal models of complex congenital heart disease.
- Sildenafil therapy for neonatal and childhood pulmonary hypertensive vascular disease.
- Pulmonary hypertension associated with congenital heart disease: pulmonary vascular disease: the global perspective.
- The role of calcium channel blockers, steroids, anticoagulation, antiplatelet drugs, and endothelin receptor antagonists.
- Abnormal pericyte recruitment as a cause for pulmonary hypertension in Adams-Oliver syndrome.
- Clinical characteristics and follow up of Down syndrome infants without congenital heart disease who presented with persistent pulmonary hypertension of newborn.
- Inhaled NO inhibits platelet aggregation and elevates plasma but not intraplatelet cGMP in healthy human volunteers.
- Early mediastinal seroma secondary to modified Blalock-Taussig shunts--successful management by percutaneous drainage.
- Diagnostic and therapeutic uses of inhaled nitric oxide in neonatal Ebstein's anomaly.
- Levels of exhaled nitric oxide before and after surgical and transcatheter device closure of atrial septal defects in children.
- Recent advances in pulmonary vascular disease.
- Inherited duplication, dup (8) (p23.1p23.1) pat, in a father and daughter with congenital heart defects.
- Improving outcomes of the Fontan operation in children with atrial isomerism and heterotaxy syndromes.
- Chylopericardium after cardiac operations in children.
- Inhaled nitric oxide and congenital cardiac disease.
- Precoronary stenosis after stage I palliation for hypoplastic left heart syndrome.
- Transverse limb defects associated with aorto-pulmonary vascular abnormalities: vascular disruption sequence or atypical presentation of Adams-Oliver syndrome?
- Angiographic findings of persistent primitive hepatic venous plexus with underdevelopment of the infrahepatic inferior vena cava in pediatric patients.
- Comparison of hyperventilation and inhaled nitric oxide for pulmonary hypertension after repair of congenital heart disease.
- MRI of Uhl's anomaly.
- Inhaled nitric oxide differentiates pulmonary vasospasm from vascular obstruction after surgery for congenital heart disease.
- Combined effects of nitric oxide and oxygen during acute pulmonary vasodilator testing.
- From functional pulmonary atresia to right ventricular restriction. Long term follow up of Uhl''s anomaly.
- Mortality in potential arterial switch candidates with transposition of the great arteries.
- Decreased exhaled nitric oxide may be a marker of cardiopulmonary bypass-induced injury.
- Total cavopulmonary anastomosis (Fontan) in children with Down's syndrome.
- Acute pulmonary embolism in a neonate: precipitation during cardiac catheterization and successful treatment.
- Truncal valve repair: initial experience in neonates.
- Nitrite and nitrate analyses: a clinical biochemistry perspective.
- Transatrial selective coronary arteriography in pulmonary atresia with intact ventricular septum.
- Disposable surgical gloves and Pasteur (Transfer) pipettes as potential sources of contamination in nitrite and nitrate assays.
- Improved oxygenation in a randomized trial of inhaled nitric oxide for persistent pulmonary hypertension of the newborn.
- Balloon angioplasty of recurrent coarctation: a 12-year review.
- Extracorporeal membrane oxygenation and the treatment of critical pulmonary hypertension in congenital heart disease.
- Clinical course and hemodynamic observations after supraannular mitral valve replacement in infants and children.
- Effect of inhaled nitric oxide on endothelin-1 and cyclic guanosine 5'-monophosphate plasma concentrations in newborn infants with persistent pulmonary hypertension.
- Rebound pulmonary hypertension after inhalation of nitric oxide.
- Diagnostic use of inhaled nitric oxide after neonatal cardiac operations.
- Inhaled nitric oxide in children with pulmonary hypertension and congenital mitral stenosis.
- Clinical applications of inhaled nitric oxide in children with pulmonary hypertension.
- Circulating endothelin in children with congenital heart disease.
- Abnormalities in the biosynthesis of thromboxane A2 and prostacyclin in children with cyanotic congenital heart disease.
- Prenatal diagnosis of primary pulmonary hypoplasia in fraternal twins.
- Use of inhaled nitric oxide and acetylcholine in the evaluation of pulmonary hypertension and endothelial function after cardiopulmonary bypass.
- Thromboxane A2 and prostacyclin biosynthesis in children and adolescents with pulmonary vascular disease.
- Delivery and monitoring of inhaled nitric oxide in patients with pulmonary hypertension.
- Severe congenital mitral stenosis in infants.
- Inhaled nitric oxide in the treatment of postoperative graft dysfunction after lung transplantation.
- Abnormalities in skeletal muscle metabolism in cyanotic patients with congenital heart disease: a 31P nuclear magnetic resonance spectroscopy study.
- Inhaled nitric oxide in chronic obstructive lung disease.
- Unroofed coronary sinus and coronary sinus orifice atresia. Implications for management of complex congenital heart disease.
- Therapeutic use of inhaled nitric oxide.
- Effect of intracardiac repair on biosynthesis of thromboxane A2 and prostacyclin in children with a left to right shunt.
- Inhaled nitric oxide and hemodynamic evaluation of patients with pulmonary hypertension before transplantation.
- Transposition of the great arteries in a neonate with Klinefelter's syndrome.
- A wire technique to cross the congenitally stenotic aortic valve.
- Prevention of early sudden circulatory collapse after the Norwood operation.
- Increased plasma levels of endothelin-1 after cardiopulmonary bypass in patients with pulmonary hypertension and congenital heart disease.
Schools
University Of Bristol
Doctors Specialties
- Pediatric Cardiology
Accepted Insurances
- Great West Healthcare-Cigna PPO
- MultiPlan PPO
- PHCS Network PPO
Education
-
Boston Children's Hospital -
University of Bristol Medical School
Helpful Reviews
Similar Doctors
|
|
Dr. Phillip Moore, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Sarina K. Behera, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Akash R. Patel, MD |
|
|
Dr. Michael R. Tyndall, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Kathleen M. Ruppel, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Lisa K. Hornberger, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Jeffery J. Meadows, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Deepak Srivastava, MD |